Joseph K. Belanoff
2017
In 2017, Joseph K. Belanoff earned a total compensation of $4.3M as Chief Executive Officer and President at Corcept Therapeutics, a 78% increase compared to previous year.
Compensation breakdown
Bonus | $702,000 |
---|---|
Option Awards | $2,922,119 |
Salary | $647,333 |
Total | $4,271,452 |
Belanoff received $2.9M in option awards, accounting for 68% of the total pay in 2017.
Belanoff also received $702K in bonus and $647.3K in salary.
Rankings
In 2017, Joseph K. Belanoff's compensation ranked 2,350th out of 14,666 executives tracked by ExecPay. In other words, Belanoff earned more than 84.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,350 | 84th |
Manufacturing | 824 | 86th |
Chemicals And Allied Products | 217 | 90th |
Drugs | 166 | 90th |
Pharmaceutical Preparations | 131 | 90th |
Belanoff's colleagues
We found four more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2017.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019